Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Consolidated Financial Results for the Six Months Ended June 30, 2025 (under IFRS)
Kubota Pharma, First Half Net Income Loss Narrows, Apr-Jun Net Income Loss Narrows
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (under IFRS)
Kubota Pharma, Jan-Mar (1Q) Net Income Loss Narrows
Consolidated Financial Results for the Fiscal Year Ended December 31, 2024 (under IFRS)
Kubota Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow
Kubota Pharmaceutical Holdings Co., Ltd., July-September (3Q) Net Income Loss Widens
Consolidated Financial Results for the Nine Months Ended September 30, 2024 (under IFRS)